NLM Logo

CAV regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
CAV regimen
Unique ID
C089190
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C089190
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Etoposide
Lomustine
Melphalan
Frequency
3
Note
a chemotherapy protocol consisting of the above compounds; used for the treatment of patients with Hodgkin's disease
Source
Ann Oncol 1994 May;5(5):427-32
Date of Entry
1994/09/30
Revision Date
2000/11/30
CAV regimen Preferred
page delivered in 0.004s